Cartesian Therapeutics Reports Third-Quarter Loss per Share
Story updates
12:13:15 PM UTC
SquawkNews
Cartesian Therapeutics 3Q Loss $11.5M >RNAC
Related stories
McGraw Hill Reports Fiscal Second-Quarter 2027 Results
The company said digital revenue growth exceeded revenue expectations and highlighted advances in agentic AI in education.
M impact | EQUITY | Nov 05, 2026, 12:25 PM UTC
Steven Madden Q3 earnings snapshot
The available report identifies Steven Madden Ltd. (SHOO) and its Q3 earnings but provides no results.
M impact | EQUITY | Nov 05, 2026, 12:17 PM UTC
Aurora Cannabis Reports Q2 Revenue of CA$86.0M
Aurora Cannabis reported Q2 revenue of CA$86.0 million, compared with a FactSet estimate of CA$71.4 million.
M impact | EQUITY | Nov 05, 2026, 12:16 PM UTC
OpenText Reports First-Quarter Revenue of $1.24 Billion
M impact | EQUITY | Nov 05, 2026, 12:16 PM UTC
Tiny Reports Q3 2026 Results
Tiny Ltd. announced financial results for the three and nine months ended September 30, 2026.
M impact | EQUITY | Nov 05, 2026, 12:16 PM UTC
Papa John's Reports $1.15B in 3Q Global System-Wide Sales
L impact | EQUITY | Nov 05, 2026, 12:16 PM UTC